English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Objective: To explore immunotherapy effectiveness of the CD4+ CD25+ regulatory T cells for treating female mouse with recurrent spontaneous abortion (RSA) by animal experiments. Methods: Mononuclear lymphocytes were isolated from the blood (instead of cord blood) of new-born baby of KunMing Bai mouse or BALB/c male mouse with normal birth ability (as unrelated third party blood source) by density gradient centrifugation method. The CD4+ CD25+ regulatory T cells were selected by magnetic-activated cell sorting from mononuclear cells of cord blood cells. CBA/J female mouse copulated with DBA/2J male mouse was utilized as RSA animal model. Pregnant RSA mice were injected different types of lymphocytes through tail vein. Independent sample t-test was used to analyze the data from each group. Results: The proportion of CD4+ CD25+ T cells in CD4+ T cells was (17.49 ± 0.60)% in CD4+ CD25+ regulatory T cells injection group, which was statistical significant higher than that of mononuclear lymphocyte injection group (14.68 ± 0.83)%, sterile PBS group (9.54 ± 0.85)% or no injection group (9.28 ± 0.68)% (p < .05, t-value was 4.754, 13.242 and 15.621, respectively). The Foxp3 relative protein expression level of CD4+ CD25+ regulatory T cells injected group was 5.85 ± 0.45, which was also significant higher than that of mononuclear lymphocyte injection (2.86 ± 0.54), sterile PBS group (1.08 ± 0.16) or no injection group (1.00 ± 0.00) (p <. 05, t-value was 7.276, 17.227 and 18.635, respectively). Finally, two times of CD4+ CD25+ T cell injected group at the 4 and 8 day had well effect for RSA mouse, and embryo sorption rate was (4.92 ± 0.08)%, which significant lower than that of two times of mononuclear lymphocyte injected group (13.07 ± 0.06)%, sterile PBS group (23.11 ± 0.12)%, or no injection group (25.47 ± 0.11)% (p <. 05, t-value was -2.603, -4.012 and -4.700, respectively). Conclusions: Pregnant mouse with RSA injected CD4+ CD25+ T cells several times for immunotherapy can get better effectiveness than that of pregnant mouse injected traditional mononuclear cells.

Animal study on CD4+ CD25+ regulatory T cells for treating female mouse with recurrent spontaneous abortion